Connect your AI

Tempus AI, Inc. TEM 2030

2030 at other companies

Guardant HealthGH

——

Natera, Inc.NTRA

——

RevvityRVTY

——

Agilent TechnologiesA

——

AbbottABT

——

AmgenAMGN

——

Other financials

Income statement

Revenue$348.1M+36.1%

Operating income-$84.7M-23.3%

Net income-$125.9M-85.1%

EPS (diluted)-$0.71-77.5%

Balance sheet

Cash & equivalents$525.9M+243%

Total debt$85.4M+49.8%

Total equity$416.4M+27.7%

Total assets$2.1B+38.4%

Cash flow

Operating cash flow-$73.3M+30.6%

CapEx$8.2M+295%

Free cash flow-$81.5M+24.3%

Valuation

Market cap$9.13B-2.7%

Enterprise value$8.69B-6.9%

P/S6.7×-5.0×

Profitability

Operating margin-19.7%-8.6pp

Net margin-22.2%-9.5pp

FCF margin-54.5%—

Returns & leverage

Return on equity-81.6%—

Debt / equity0.2×0.0×

Current ratio3.3×+1.6×

Where this comes from

Reported directly by Tempus AI, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour.

The official record: Tempus AI, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tempus AI, Inc.'s 2030.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Tempus AI, Inc.'s 2030?: Tempus AI, Inc. (TEM) reported 2030 of $40.23M in Q1 2026.